YARW Yarrow Bioscience, Inc.

Fundamentals / CIK 0001566044 / USD
Other share classes on CIK 0001566044: VYNE

Yarrow Bioscience, Inc. reported $570K in revenue and a net loss of $26.48M for the fiscal year ended December 31, 2025 (up 13.8% year over year), with a -5219.1% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open YARW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$47.68M$23.84M$0-$240.7MFY 2016 Revenue: $674KFY 2016 Net Income: -$14.07M2016FY 2017 Revenue: $4.58MFY 2017 Net Income: -$29.08M2017FY 2018 Revenue: $0FY 2018 Net Income: -$74.16M2018FY 2019 Revenue: $0FY 2019 Net Income: -$95.18M2019FY 2020 Revenue: $20.99MFY 2020 Net Income: -$255.6M2020FY 2021 Revenue: $931KFY 2021 Net Income: -$73.33M2021FY 2022 Revenue: $477KFY 2022 Net Income: -$23.21M2022FY 2023 Revenue: $424KFY 2023 Net Income: -$28.45M2023FY 2024 Revenue: $501KFY 2024 Net Income: -$39.83M2024FY 2025 Revenue: $570KFY 2025 Net Income: -$26.48M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $570K $501K $424K $477K $931K $20.99M $0 $0 $4.58M $674K
Cost of Revenue -- -- -- -- $3.35M $1.39M $0 $0 -- --
Gross Profit -- -- -- -- -$2.42M $19.60M $0 $0 -- --
Research & Development $19.24M $30.95M $16.31M $18.39M $19.54M $43.53M $51.20M $64.47M $29.01M $11.26M
Selling, General & Admin -- -- -- $16.39M $20.30M $89.54M $45.11M $14.01M -- --
Total Operating Expenses -- -- -- -- -- -- $76.24M $65.17M $34.17M $15.01M
Operating Income -$29.75M -$43.64M -$29.26M -$34.30M -$38.91M -$252.5M -$95.87M -$74.89M -$29.59M -$14.33M
EBITDA -$29.73M -$43.63M -$29.26M -$34.22M -$38.80M -$252.2M -$95.52M -$74.57M -- --
Interest Expense -- -- -- $0 $5.61M $4.39M $921K $0 -- --
Income Before Tax -$26.73M -$39.80M -$27.87M -$33.93M -$44.66M -$255.8M -$95.35M -$73.95M -- --
Income Tax Expense $4.0K $4.0K $0 $13K -$448K -$258K -$176K $212K $0 --
Net Income -$26.48M -$39.83M -$28.45M -$23.21M -$73.33M -$255.6M -$95.18M -$74.16M -$29.08M -$14.07M
Basic EPS -$31.00 -$46.50 -$139.00 -$364.00 -$23,057.55 $7,086.33 $40,359.71 $41,258.99 -$20,467.63 -$10,143.88
Diluted EPS -$31.00 -$46.50 -$139.00 -$364.00 -$23,057.55 $7,086.33 $40,359.71 $41,258.99 -$20,467.63 -$10,143.88
Basic Shares Outstanding 855.4K 851.8K 205.5K 63.7K 3.2K 36.0K 2.4K 1.8K 1.4K 1.4K
Diluted Shares Outstanding 855.4K 851.8K 205.5K 63.7K 3.2K 36.0K 2.4K 1.8K 1.4K 1.4K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue -- $97K $86K $69K $202K $84K $121K $198K
Research & Development $5.28M $788K $817K $4.88M $6.12M $9.68M $10.25M $7.31M
Operating Income -$10.74M -$3.10M -$3.82M -$7.54M -$9.20M -$12.77M -$13.09M -$10.40M
EBITDA -$10.75M -$3.10M -$3.81M -$7.54M -$9.19M -- -- -$10.40M
Income Before Tax -- -$2.90M -$3.58M -$5.75M -$8.60M -$12.01M -$12.16M -$9.39M
Income Tax Expense -- $0 $0 $0 $0 $4.0K $0 $0
Net Income -$9.72M -$6.51M -$2.75M -$5.75M -$8.61M -$12.02M -$12.16M -$9.41M
Basic EPS -$0.43 -$3.51 -$4.00 -$6.73 -$10.00 -- -$14.50 -$11.00
Diluted EPS -$0.43 -$3.51 -$4.00 -$6.73 -$10.00 -- -$14.50 -$11.00
Basic Shares Outstanding 22.6M 858.0K 855.4K 855.0K 853.5K -- 851.7K 851.7K
Diluted Shares Outstanding 22.6M 858.0K 855.4K 855.0K 853.5K -- 851.7K 851.7K

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $99.99M $19.93M $30.62M $30.91M $42.25M $57.56M $43.76M $27.87M $10.21M $4.03M
Short-Term Investments $4.98M $41.59M $62.63M $0 $0 $1.03M $16.68M $86.74M $49.30M $26.88M
Cash & Short-Term Investments $105.0M $61.52M $93.25M $31.00M $42.90M $59.40M $60.44M $136.2M $59.50M $30.91M
Accounts Receivable, Net -- -- -- $173K $7.58M $15.82M $135K -- $786K $0
Inventory -- -- -- -- $7.29M $7.40M $1.36M -- -- --
Total Current Assets $100.0M $64.44M $95.96M $38.27M $63.19M $87.26M $76.41M $139.5M $63.86M $31.54M
Property, Plant & Equipment, Net $0 $113K $0 $0 $354K $555K $2.88M $146K $28K $27K
Long-Term Investments -- -- -- -- -- -- -- -- $2.98M $10.42M
Other Non-Current Assets $407K -- -- -- -- $4.34M $166K -- $0 --
Total Non-Current Assets $407K $2.47M $1.72M $2.48M $3.86M $6.48M $4.75M $428K $3.01M $10.51M
Total Assets $100.4M $66.91M $97.69M $40.76M $67.05M $93.74M $81.16M $139.9M $66.87M $42.05M
Accounts Payable $1.53M $2.71M $1.66M $2.39M $6.51M $4.78M $3.77M $3.29M $2.46M $1.53M
Short-Term Debt -- -- -- -- -- $0 -- -- -- --
Deferred Revenue (Current) -- -- -- -- -- -- -- -- $1.80M $1.80M
Other Current Liabilities $0 $1.31M $0 -- $0 $104K $270K -- -- --
Total Current Liabilities $71.55M $14.82M $7.54M $9.35M $18.41M $21.77M $29.33M $9.54M $7.82M $3.90M
Long-Term Debt $0 $0 $0 $0 $0 $33.17M $32.73M -- -- --
Deferred Revenue (Non-Current) -- -- -- -- -- -- -- -- $6.74M $8.53M
Other Non-Current Liabilities -- -- -- -- -- -- -- $7.0K $22K $57K
Total Non-Current Liabilities $0 $0 $1.41M $0 $0 $34.48M $34.26M $7.0K $6.76M $8.59M
Total Liabilities $71.55M $14.82M $8.95M $9.35M $18.41M $56.25M $63.58M $9.55M $14.57M $12.49M
Total Debt (incl. Leases) $0 $99K $214K $0 $349K $34.78M $34.47M -- -- --
Common Stock $0 $1.0K $1.0K $0 $5.0K $4.0K $1.0K $3.0K $1.0K $1.0K
Retained Earnings -$70.99M -$731.2M -$691.3M -$662.7M -$639.5M -$566.2M -$310.6M -$110.6M -$59.19M -$30.11M
Accumulated Other Comp. Income $2.0K $20K $26K $0 $0 $0 $5.0K -$96K -$51K -$26K
Total Stockholders' Equity -$70.99M $52.09M $88.73M $31.20M $48.64M $37.49M $17.57M $92.18M $68.60M -$29.44M
Total Equity -$70.99M $52.09M $88.73M $31.20M $48.64M $37.49M $17.57M $92.18M $68.60M -$29.44M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents $268.9M $22.93M $24.63M $99.99M $22.05M $28.21M $19.93M $16.27M
Short-Term Investments -- $0 $297K $4.98M $17.60M $22.06M $41.59M $53.91M
Cash & Short-Term Investments $268.9M $22.93M $24.93M $105.0M $39.65M $50.27M $61.52M $70.19M
Total Current Assets $274.0M $23.53M $25.79M $100.0M $44.34M $54.91M $64.44M $73.53M
Property, Plant & Equipment, Net $72K $78K $84K $0 $102K $107K $113K --
Other Non-Current Assets $0 -- -- $407K -- -- -- --
Total Non-Current Assets $72K $78K $84K $407K $375K $1.51M $2.47M $2.66M
Total Assets $274.0M $23.60M $25.87M $100.4M $44.72M $56.42M $66.91M $76.20M
Accounts Payable $2.13M $614K $261K $1.53M $1.41M $3.53M $2.71M $3.99M
Other Current Liabilities -- -- -- $0 $0 $1.31M $1.31M $1.31M
Total Current Liabilities $6.51M $1.54M $1.24M $71.55M $5.84M $12.29M $14.82M $12.66M
Long-Term Debt $0 $0 $0 $0 $0 $0 $0 $0
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $6.51M $1.54M $1.24M $71.55M $5.84M $12.29M $14.82M $12.66M
Total Debt (incl. Leases) $0 $0 $0 $0 $25K $63K $99K $123K
Common Stock $1.0K $0 $3.0K $0 $2.0K $2.0K $1.0K $1.0K
Retained Earnings -$89.97M -$764.2M -$761.2M -$70.99M -$745.5M -$739.8M -$731.2M -$719.1M
Accumulated Other Comp. Income -- $0 $0 $2.0K -$2.0K $0 $20K $34K
Total Stockholders' Equity $267.5M -$79.43M -$73.43M -$70.99M $38.88M $44.13M $52.09M $63.54M
Total Equity $267.5M -$79.43M -$73.43M -$70.99M $38.88M $44.13M $52.09M $63.54M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$26.48M -$39.83M -$28.45M -$23.21M -$73.33M -$255.6M -$95.18M -$74.16M -$29.08M -$14.07M
Depreciation & Amortization $23K $4.0K $0 $72K $109K $341K $350K $319K -- --
Stock-Based Compensation $2.31M $3.30M $3.31M $4.30M $8.08M $18.10M $4.89M $5.32M $5.32M $573K
Change in Receivables -- -- -- -- -- -- -- $786K -$786K $0
Change in Inventory -- -- $0 $97K $113K -$6.05M -$1.36M $0 -- --
Change in Payables -- -- -- -- -- -- $481K $825K $620K $889K
Operating Cash Flow -$33.12M -$33.97M -$25.34M -$29.20M -$56.37M -$137.1M -$73.39M -$68.66M -$28.22M -$2.27M
Capital Expenditure $0 -$117K $0 -- $0 -$113K -$1.06M -$567K -$27K -$31K
Free Cash Flow -$33.12M -$34.09M -$25.34M -- -$56.37M -$137.2M -$74.45M -$69.23M -$28.25M -$2.30M
Purchases of Investments -$30.93M -$60.52M -$62.35M $0 -- $0 -$83.40M -$126.7M -$64.15M -$55.31M
Sales & Maturities of Investments -- -- -- -- -- -- $124.8M $92.96M $49.09M --
Investing Cash Flow $37.37M $23.36M -$57.35M $15.67M $1.03M $89.11M $41.87M -$11.76M -$15.09M -$37.52M
Common Stock Issued -- -- -- $1.47M $75.98M $61.64M $13.71M $91.49M -- --
Financing Cash Flow -$143K -$141K $82.39M $1.65M $39.78M $61.81M $47.95M $92.37M $49.49M $0
Net Change in Cash $4.10M -$10.75M -$301K -$11.88M -$15.56M $13.83M -$18.73M $39.30M $6.18M -$39.78M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Net Income -$9.72M -$6.51M -$2.75M -$5.75M -$8.61M -$12.02M -$12.16M -$9.41M
Depreciation & Amortization -$8.0K $6.0K $6.0K $6.0K $6.0K -- -- $0
Stock-Based Compensation $608K $436K $474K $529K $763K $699K $734K $885K
Operating Cash Flow -$89.96M -$1.99M -$4.08M -$10.80M -$11.46M -$9.00M -$8.51M -$8.48M
Purchases of Investments -- $0 $0 -$9.57M -$13.77M -$10.04M -$28.42M -$6.88M
Investing Cash Flow -- $300K $4.70M $4.67M $19.83M $12.74M -$4.82M $19.02M
Common Stock Issued -- -- -- -- -- -- $0 $0
Financing Cash Flow $265.0M -$14K -$15K -$34K -$87K -$132K -$2.0K -$2.0K
Net Change in Cash $170.1M -$1.71M $604K -$6.16M $8.28M $3.61M -$13.34M $10.54M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin -- -- -- -- -259.6% 93.4% -- -- -- --
Operating Margin -5219.1% -8710.0% -6900.5% -7189.7% -4179.5% -1203.0% -- -- -645.9% -2126.4%
Net Profit Margin -4646.1% -7950.9% -6710.4% -4865.8% -7876.4% -1217.4% -- -- -634.6% -2087.2%
Return on Equity (ROE) -- -76.5% -32.1% -74.4% -150.8% -681.6% -541.6% -80.5% -42.4% --
Return on Assets (ROA) -26.4% -59.5% -29.1% -56.9% -109.4% -272.6% -117.3% -53.0% -43.5% -33.5%
Current Ratio 1.40x 4.35x 12.73x 4.10x 3.43x 4.01x 2.61x 14.62x 8.17x 8.08x
Quick Ratio 1.47x 4.15x 12.37x 3.34x 3.04x 3.67x 2.56x 14.28x 7.71x 7.92x
Debt to Equity -- 0.00x 0.00x 0.00x 0.01x 0.93x 1.96x -- -- --
Revenue Growth (YoY) +13.8% +18.2% -11.1% -48.8% -95.6% -- -- -100.0% +579.8% --
Gross Profit Growth (YoY) -- -- -- -- -112.3% -- -- -- -- --
EPS Growth (YoY) -- -- -- -- -425.4% -82.4% -2.2% -- -- --
5Y Revenue / Share Growth -99.9% -- -- -99.8% -39.8% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Operating Margin -- -- -- -8949.6% -7513.1% -8710.0% -7646.9% -6346.1%
Net Profit Margin -- -- -- -8097.7% -6974.5% -7950.9% -6896.6% -5849.2%
Return on Equity (ROE) -- -- -- -99.1% -95.6% -76.5% -53.5% -38.0%
Return on Assets (ROA) -- -- -- -86.2% -74.8% -59.5% -44.6% -32.8%
Current Ratio 42.08x 15.26x 20.86x 7.60x 4.47x 4.35x 5.81x 7.13x
Quick Ratio 41.29x 14.87x 20.17x 6.79x 4.09x 4.15x 5.54x 6.64x
Debt to Equity 0.00x -- -- 0.00x 0.00x 0.00x 0.00x 0.00x
Revenue Growth (YoY) -- +40.6% -57.4% -65.2% +106.1% +10.5% +6.1% +46.7%
Source: SEC EDGAR CompanyFacts (CIK 0001566044) · from December 31, 2015 Data through September 30, 2026 · synced Nov 20, 2026, 05:47 UTC · Open in terminal